aTyr Pharma
CompanyUnited StatesFounded 2005
aTyr Pharma develops one asset, preclinical (ATYR0101 in fibrosis). Mostly protein or enzyme acting on DARS1; based in the United States, founded in 2005.
- 1
- Asset
- Furthest stage
- Preclinical
- 0
- Trials
- 0
- Signals
Pipeline
1DARS-derived Fc fusion protein
Preclinical, Protein or enzyme, DARS1, fibrosis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6